About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Expert Consensus

Multidisciplinary international expert consensus on perioperative airway management
Hengrui Liang, Guowei Che, Fei Cui, Junguo Dong, Weiquan Gu, Chundong Gu, Shun Xu, Yufeng Ba, Kaican Cai, Qingdong Cao, Chang Chen, Chun Chen, Qixun Chen, Liyang Cheng, Gang Feng, Yunjiu Gou, Wenwei Guo, Jinxi He, Junming He, Jian Hu, Ying Huang, Wenxi Wang, Wenjie Jiao, Shunjun Jiang, Jun Liu, Lan Lan, Wei Li, Xiaofei Li, Zhongcheng Li, Yin Li, Zhu Liang, Hongxu Liu, Yingbin Liu, Xinyu Mei, Xicheng Song, Daqiang Sun, Hui Tian, Ziqiang Tian, Jianhua Wang, Guangsuo Wang, Xin Xu, Xudong Xiang, Guobing Xu, Tao Xue, Chao Yang, Xiaolong Yan, Nuo Yang, Feng Yao, Dalong Yin, Xiaochuan Yin, Bentong Yu, Wei Zhai, Yu Zhang, Guangjian Zhang, Xiaowen Zhang, Qiang Zhang, Yi Zhang, Jun Zhao, Haihui Zhong, Alessandro Brunelli, Till Ploenes, Luca Bertolaccini, John Kit Chung Tam, Min P. Kim, Majed Refai, Michel Gonzalez, Adam R. Dyas, Nicoletta Pia Ardò, Hiran C. Fernando, Giulio Maurizi, Gregor J. Kocher, Giuseppe Marulli, Álvaro Fuentes-Martín, Gianluca Perroni, Kyung Soo Kim, Maria Rodriguez, Marcus Taylor, Xusen Zou, Wei Wang, Jianxing He

Original Article

Deep learning model for predicting spread through air spaces of lung adenocarcinoma based on transfer learning mechanism
Jia-Ning Zhang, Zhuo-Fu Li, Sun-Yi Zheng, Jiao-Jiao Li, Lei-Na Sun, Zhao-Xiang Ye
Integrating radiomics and deep learning for enhanced prediction of high-grade patterns in stage IA lung adenocarcinoma
Zhongxiao Chen, Hao Liu, Hua Sun, Cheng Xu, Bingyu Hu, Luyu Qu, William C. Cho, Thivanka Witharana, Chengchu Zhu, Jianfei Shen
DNA damage and repair (DDR) gene mutation profiles in driver gene wild-type advanced non-small cell lung cancer and the predictive role of response to platinum-based chemotherapy
Tianxiu Wu, Yu Xu, Qiuyue Song, Xiuqing Liao, Wei Yao, Guangsong Wang, Yu Yang, Bin Wang, Liang Guo, Mingzhou Zhang, Guoming Wu, Li Luo, Li Bai, Yan Wang, Mingdong Hu, Zhi Xu
Using human genetics to understand the epidemiological association between neuroticism and lung cancer
Dongsheng Wu, Yongcheng Liu, Shuqiao Liu, Xiaohu Hao, Xin Li, Quan Zheng, Tengyong Wang, Yuchen Huang, Shiyou Wei, Jian Zhou, Lunxu Liu
Development and validation of machine learning models based on molecular features for estimating the probability of multiple primary lung carcinoma versus intrapulmonary metastasis in patients presenting multiple non-small cell lung cancers
Ning Liu, Xue Li, Xu Luo, Bin Liu, Jie Tang, Fei Xiao, Weiya Wang, Yuan Tang, Pei Shu, Benxia Zhang, Yue Chen, Diyuan Qin, Qizhi Ma, Fuchun Guo, Xiaojun Tang, Daxing Zhu, Jiandong Mei, Weizhi Chen, Dan Li, Lili Jiang, Yongsheng Wang
Exosomal miR-182-5p is a potential diagnostic marker for malignant pleural effusion
Wen Zhao, Jian-Xun Wen, Yan Niu, Li Yan, Mei-Ying Wang, Wei Jiao, Ya-Fei Wang, Wen-Hui Gao, Dan-Ni Yang, Wen-Qi Zheng, Zhi-De Hu
Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy
Ji Eun Park, Chanmi Kim, Sun Ha Choi, Jong Geol Jang, Kyung Soo Hong, Yong Shik Kwon, Keum-Ju Choi, Jung Seop Eom, Saerom Kim, Hee Yun Seol, Jehun Kim, Insu Kim, Jin Han Park, Tae Hoon Kim, June Hong Ahn
Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study
Xue Yang, Yutao Liu, Gen Lin, Jinliang Wang, Yudong Wang, Yan Zhang, Qinxiang Guo, Fei Liang, Jun Zhao, Bo Jin, Xiaorong Dong
Integrative radiomics analysis of peri-tumoral and habitat zones for predicting major pathological response to neoadjuvant immunotherapy and chemotherapy in non-small cell lung cancer
Dan Han, Junfeng Zhao, Shaoyu Hao, Shenbo Fu, Ran Wei, Xin Zheng, Qian Zhao, Chengxin Liu, Hongfu Sun, Chengrui Fu, Zhongtang Wang, Wei Huang, Baosheng Li
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan
Shiho Goda, Tadaaki Yamada, Kenji Morimoto, Tae Hata, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Asuka Okada, Makoto Hibino, Yusuke Chihara, Takashi Kijima, Koichi Takayama
Diagnostic accuracy of serum biomarkers MMP11 and SPP1 in non-small cell lung cancer: an analysis of sensitivity, specificity, and area under the curve
Minha Lea Yoon, Sang Yean Kim, Hyelim Chun, Jina Park, Woo-Jeong Seo, Jung Young Lee, Jung Hwan Yoon
Comparing neutrophil-to-lymphocyte ratio (NLR), absolute neutrophil count (ANC) and derived NLR as predictive biomarkers in first-line immunotherapy for non-small cell lung cancer: a retrospective study
Elise Longueville, Maxime Dewolf, Véronique Dalstein, Anne Durlach, Alexandre Vivien, Béatrice Nawrocki-Raby, Myriam Polette, Gaëtan Deslée, Julien Ancel
Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial
Baohui Han, Lin Wu, Runxiang Yang, Hongbo Wu, Wei Li, Yan Yu, Mingjuan Zhang, Hongmei Sun, Tianqing Chu, Fukuan Zhong, Yong Fang, Rong Wu, Tao Bian, Xiaoqing Guo, Meili Sun, Yanming Zhang, Lianke Liu, Xuewen Liu, Yueyin Pan, Ou Jiang, Zonghui Wei, Haifeng Lin, Wei Guo, Jian Fang, Jialei Wang, Cuimin Ding, Yanping Hu, Feng Ye, Wu Zhuang, Shucheng Ye, Lihong Wang, Zhe Huang, Chang Liu, Ling Yang, Jinling Wang, Liangzhi Xie
Metabolic tumor volume on 18F-FDG uptake as a negative predictor after ipilimumab plus nivolumab in advanced non-small cell lung cancer
Kosuke Hashimoto, Kyoichi Kaira, Atsuto Mouri, Ayako Shiono, Yu Miura, Ou Yamaguchi, Hisao Imai, Hiroshi Kagamu, Ichiei Kuji
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study
Mar Varela, Cristina Teixidó, Carlos Álvarez-Fernández, Hugo Arasanz, Sergio Peralta, Martín Lázaro, Virginia Calvo, Rosa Álvarez, Javier Baena, Javier Valdivia, Edurne Arriola, Reyes Bernabé, Dolores Isla, Carmen Camacho, Bartomeu Massutí, Ana Blasco, Teresa García, Manuel Cobo, Marc Campayo, Sara Hijazo-Pechero, Ángel Callejo, Marta Domínguez, Ernest Nadal
Tracheobronchial resection and reconstruction: to wrap or not to wrap the anastomosis?
Chudong Wang, Zihao Liu, Rui Wang, Biao Hu, Binbin Xiang, Zijian Li, Jianxing He, Shuben Li
Uniportal video-assisted thoracoscopic surgery does not increase recurrence rates following pneumonectomy in non-small cell lung cancer: a retrospective study from the National Cancer Center of China
Sikai Wu, Xiaowei Chen, Guangyu Bai, Yang Liu, Zhenlin Yang, Shugeng Gao
Budesonide/glycopyrronium/formoterol fumarate co-suspension metered dose inhaler relieves cough after lobectomy: a randomized controlled study
Junguo Dong, Shunjun Jiang, Yuan Qiu, Jingpei Li, Fei Cui, Hengrui Liang, Shen Lao, Zixian Xie, Jun Huang, Zhexue Hao, Huanghe He, Xin Xv, Man Zhang, Miao He, Yuan Zhang, Jianxing He, Wei Wang
Characterization of the xeno-GVHD response generated by advanced lung cancer patient peripheral blood mononuclear cells in NSG-SGM3 mice
Vered Fuchs, Laila Roisman, Maha Msamra, Yael Refaely, Aharon Yehonatan Cohen, Angel Porgador, Nir Peled, Ariel Sobarzo
FOXO3a regulation of non-small cell lung cancer radiotherapy resistance through the PINK1/Parkin pathway of protective mitophagy
Xiaoting Wu, Litang Huang, Lu Meng, Shilan Luo, Paola Anna Jablonska, Chi Zhang, Anqi Zhang, Peng Li, Xiaomei Gong
Predictive value of the monocyte-to-high-density lipoprotein ratio in the prognosis of non-small cell lung cancer patients after surgery
Yi Liu, Wen-Long Zhang, Song-Ping Cui, Aimée J. P. M. Franssen, Erik R. de Loos, Yuichiro Ueda, Takahiro Homma, James Shahoud, Qing Zhao, Yang Gu, Yi-Li Fu, Bin Hu
LNCAROD was stabilized through N6-methyladenosine methylation and exerted its anticancer effects in lung squamous cell carcinoma by inhibiting SIRT1 activity via CCAR2
Qihang Yan, Wingshing Wong, Jinsong Lei, Dachuan Liang, Jie Yang, Li Gong, Rossana Berardi, Shuqin Dai, Junye Wang
Efficacy and safety of anlotinib plus EGFR tyrosine kinase inhibitors in slow- or locally progressing non-small cell lung cancer after adjuvant therapy
Jiayue Ye, Jiacong Liu, Yucheng Ma, Wang Lv, Wenzhen Xu, Masaya Aoki, Yuhong Yang, Pinghui Xia, Luming Wang, Linhai Zhu, Jian Hu
Clinical implication of tumor spread through air spaces in stage IA lung adenocarcinoma: prognostic impact and association with the International Association for the Study of Lung Cancer (IASLC) grade
Jinghan Shi, Kuan Xu, Xufeng Liu, Martin P. Barr, Jeffrey B. Velotta, Ninh M. La-Beck, Chenxi Zhong, Feng Yao
Identification and validation of diagnostic alternative splicing events in tumor-educated platelets for non-small cell lung cancer in patients with ground-glass opacity: a multicenter study
Mengqi Shao, Wanwen Li, Jieming Cao, Li Wang, Shenglong Xie, Yan Hu, Gang Feng, Feredun Azari, Luca Bertolaccini, Wenliang Liu, Bin He
Effect of the number of induction chemotherapy cycles on the efficacy of first-line atezolizumab combined with chemotherapy in extensive-stage small cell lung cancer
Mengxing You, Jiayu Liu, Fei Teng, Lige Wu, Haifeng Qin, Yan Zhang, Cuiying Zhang, Ziling Liu, Kewei Ma, Esteban C. Gabazza, Jacopo Vannucci, Xuezhi Hao, Junling Li, Puyuan Xing
Nanoassemblies loaded with low-dose paclitaxel can enhance the response of lung cancer immunotherapy by activating dendritic cells
Jianlin Long, Dairong Li, Wei Zhao, Guanzhong Liang, Lumi Huang, Shuangyi Lei, Yan Li
Review Article 
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa, Shaker A. Mousa
Published online: 30 June 2016
Review Articles 
Irreversible EGFR-TKIs: dreaming perfection
Lorenza Landi, Federico Cappuzzo
Published online: 14 January 2013
Review Article 
Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology
Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group
Published online: 28 February 2017
Review Article 
Recurrence after surgery in patients with NSCLC
Hidetaka Uramoto, Fumihiro Tanaka
Published online: 28 August 2014
Review Article 
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song
Published online: 30 June 2019
Review Article 
The past, present and future of immunotherapy against tumor
Tao Jiang, Caicun Zhou
Published online: 24 June 2015
Review Article 
Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights
Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi
Published online: 28 August 2018
Review Article 
The epidemiology of lung cancer
Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden
Published online: 14 June 2018
Review Article 
Lung cancer screening: nodule identification and characterization
Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser
Published online: 14 June 2018
Review Articles 
KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach
Javier de Castro Carpeño, Cristóbal Belda-Iniesta
Published online: 03 April 2013
Review Article 
Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey
Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda
Published online: 30 June 2019
Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer 
Biology of invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hyo Sup Shim
Published online: 11 October 2017
Consensus 
Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)
Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen
Published online: 28 August 2021
Review Article 
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Published online: 19 April 2015
Review Articles 
New TNM classification: achievements and hurdles
Peter Goldstraw
Published online: 17 August 2013
Review Articles 
Angiogenesis in cancer: anti-VEGF escape mechanisms
Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski
Published online: 18 February 2012

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis
Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song
BRAF mutations in non-small cell lung cancer
Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper
The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer
Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper
Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice
Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song
Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song
Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer
Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen
The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants
Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden
The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices
Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement
Hyojin Kim, Jin-Haeng Chung
Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review
Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao
Clinical trials for lung cancer in China
Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu
Recurrence after surgery in patients with NSCLC
Hidetaka Uramoto, Fumihiro Tanaka
Prognostic markers in lung cancer: is it ready for prime time?
Chang-Qi Zhu, Ming-Sound Tsao
Potential biomarkers for lung cancer screening
Gabriella Sozzi, Mattia Boeri
Particle therapy in non-small cell lung cancer
Zhongxing Liao, Charles B. Simone II
Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions
Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai
Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer
Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors
Suchit H. Patel, Andreas Rimner, Roger B. Cohen
Intraoperative near-infrared imaging of mesothelioma
Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal
BAP1, a tumor suppressor gene driving malignant mesothelioma
Mitchell Cheung, Joseph R. Testa
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation
Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Jordan Dozier, Hua Zheng, Prasad S. Adusumilli
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
Linda O’Flaherty, Harriet Wikman, Klaus Pantel
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Sumitra Mohan, Francesca Chemi, Ged Brady
Biophysical technologies for understanding circulating tumor cell biology and metastasis
Derrick W. Su, Jorge Nieva
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno
Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer
Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis
Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

Editorials

Dulanermin in cancer therapy: Still much to do
Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data
Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner
Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung
Pedro Mendez, Jose Luis Ramirez
Role of HGF/MET axis in resistance of lung cancer to contemporary management
Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr
Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review
Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack
Lorenza Landi, Federico Cappuzzo

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hyo Sup Shim
Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Original Article
Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression
Hayato Kawachi, Tae Hata, Tadaaki Yamada, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Yusuke Chihara, Takashi Kijima, Koichi Takayama
Published online: 22 May 2025
Editorial
Pneumonectomy—a necessary evil?
Koen C. H. A. Verkoulen, Lars Geenen, Aimée J. P. M. Franssen, Lori M. van Roozendaal, Jean H. T. Daemen, Karel W. E. Hulsewé, Yvonne L. J. Vissers, Michel Gonzalez, Francesco Guerrera, Erik R. de Loos
Published online: 20 May 2025